Changes in the healthcare world are likely to limit opportunities for young researchers, especially women.Three leaders in hematology — Belinda Avalos, Sarah O’Brien, and Marty Liggett — share the initiatives they’re taking to mentor the next generation of hematologists during these challenging times.
Research symposia focus on new combinations and medication formulations for both obesity and type 2 diabetes, as well as new approaches for type 1 diabetes…
Many Medicare Advantage plans are not delivering better, more efficient care than traditional Medicare, and they need more oversight and accountability, Madelaine A. Feldman, MD,…
Transforming Gastric and GEJ Cancer Care With Perioperative Immunotherapy: Latest Updates From Chicago
An international expert panel has developed the first consensus-based framework for reporting ‘set and setting’ variables in psychedelic clinical trials.
Join us in for the 26th annual Las Vegas Dermatology seminar for the latest advancements in psoriasis, acne management and treatment, rosacea, cutaneous malignancies, and…
Cannabis users have significantly higher risks for dying from cardiovascular disease, according to a sweeping new study, prompting experts to call for tobacco-style regulation.
Naval Daver, MD, a hematologist-oncologist who has led more than 100 clinical trials, predicts the next 5 years will see successful development of cellular therapies…
Despite recent outbreaks, most adults who were vaccinated as children or previously in adulthood remain at low risk.
Epilepsy prevalence is significantly higher among people with frontotemporal dementia, with some patients reporting epilepsy up to 10 years before diagnosis of frontotemporal dementia.
